News and thought leadership
Subscribe to our latest updates, reports and upcoming events. Subscribe >
Showing 1 - 10 of 84
Life sciences report 2023: trends and future risks
This report highlights key legal and regulatory developments in the UK and the EU – and the related liability risks. Our experts also shine a spotlight on a number of priority topics for life sciences businesses, and their insurers, to consider as they plan for operational resilience in the months ahead.
The Consumer Protection Act 1987: staying put… for now
The European Commission (EC) has published its long awaited proposals to modernise the Product Liability Directive (PLD) – the legislation governing redress for defective products. The proposals address the risks and challenges posed by the digital age and have raised questions as to whether UK might follow in the EU’s footsteps and seek to reform the Consumer Protection Act 1987 (CPA), the legislation which implemented the PLD into UK law.
Kennedys continues Legal 500 success with 2023 EMEA rankings
The Legal 500 EMEA 2023 has once again recognised Kennedys as a leading firm across the region.
The Windsor Framework: implications for healthcare and life sciences industries
After years of Brexit uncertainty for businesses in the healthcare and life sciences sectors, the Windsor Framework was published on 27 February 2023 following extensive EU/UK negotiations. The Framework should pave the way for the smooth supply of medicines from Great Britain to Northern Ireland, much to the relief of industry stakeholders and patients alike.
Regulating AI in the life sciences sector
Financier Worldwide (FW) discusses regulating AI in the life sciences sector with Samantha Silver, Sarah-Jane Dobson, Charlie Whitchurch and Paula Margolis at Kennedys Law LLP.
Products law and life sciences: market insights November 2022
A summary of recent legal and regulatory developments in products law through the lens of the 'S' in ESG - environmental, social and governance. Social factors often receive less attention than their environmental and governance counterparts, but are of growing importance for businesses and their insurers.
Psychedelics: turn on, tune in, but no time to drop out
Recent statistics from the World Health Organisation suggest that the COVID-19 pandemic triggered a 25% increase in the prevalence of anxiety and depression worldwide, sounding a very clear warning that all countries need to vastly improve their mental health services, treatment and support. In this article, we look at how psychedelic treatment is viewed by insurers as a possible medical solution for people who suffer with major depressive disorder.
The ‘responsible’ Responsible Person – the complexities of ESG product compliance obligations for the life sciences industry
Whilst environmental and social governance (ESG) issues and related concepts are increasingly mainstay product compliance requirements to bring products to market in Europe, the life sciences industry continues to grapple with the unique challenges it faces when seeking to navigate, and apply, several broad-brush product compliance requirements to life sciences products.
A brave new world for product liability?
On 28 September 2022, the European Commission (EC) published its proposals to reform the EU Product Liability Directive (85/374/EEC) (PLD). We set out key points here, although there will be much to digest and discuss as to the potential impact of the proposals, should they be adopted.
Guidelines on key compliance requirements for the Personal Data Protection Act in Thailand
After several years of delays the Personal Data Protection Act B.E. 2562 (2019) ("PDPA") came into force in Thailand on 1 June 2022. Since then, on 20 June 2022, subordinate legislation (the "Notifications") under the PDPA was issued by the Personal Data Protection Committee ("PDPC") and published in the Royal Thai Government Gazette.
These Notifications are intended to set out the various criteria and rules, as well as much needed guidance and clarification, of some key requirements under the PDPA.